— Know what they know.
Not Investment Advice

MRZM OTC

Marizyme, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +29900.0% 3Y: -99.7% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 50 · $39538 mcap · 86M float · 0.0021% daily turnover · Short 100% of daily vol

Balance Sheet Trends

Total Assets
$22M -43.1% ▼
5Y CAGR: -5.1%
Total Liabilities
$29M +35.0% ▲
5Y CAGR: +267.6%
Shareholders Equity
-$5M -126.8% ▼
Cash & Investments
$148K -70.9% ▼
5Y CAGR: +327.5%
Total Debt
$21M +286.6% ▲
Net Debt
$21M +324.2% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$90$3M$4M$511K$148K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$90$3M$4M$511K$148K
Net Receivables$0$41K$50K$103K$96K
Inventory$0$56K$22K$216K$25K
Other Current Assets$0$0$0$0$0
Total Current Assets$90$3M$4M$2M$969K
Property, Plant & Equip.$2K$1M$1M$1M$1M
Goodwill & Intangibles$29M$42M$60M$35M$20M
Long-Term Investments$0-$7M$0$0$0
Other Non-Current Assets-$2K$374K$369K$369K$152K
Total Non-Current Assets$29M$44M$62M$37M$21M
Total Assets$29M$47M$66M$39M$22M
— Liabilities —
Accounts Payable$270K$326K$1M$1M$2M
Short-Term Debt$0$243K$128K$1M$20M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0-$113K$1M$0$230K
Total Current Liabilities$270K$721K$3M$3M$23M
Long-Term Debt$0$0$495K$3M$0
Other Non-Current Liab.$0$0$14M$15M$5M
Total Non-Current Liabilities$270K$1M$15M$18M$6M
Total Liabilities$270K$2M$18M$21M$29M
— Equity —
Common Stock$61K$36K$41K$41K$132K
Retained Earnings-$31M-$37M-$48M-$86M-$151M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$28M$45M$48M$17M-$5M
Total Liabilities & Equity$29M$47M$66M$39M$22M
— Key Metrics —
Total Debt$0$1M$2M$5M$21M
Net Debt-$90-$2M-$2M$5M$21M
Total Investments$0-$7M$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms